Date: October 26-28, 2021
Organised by: Hansonwade
As an increasing number of candidates enter the clinic and promise to be a mainstay in the future of cancer treatment, CGT poses unique supply chain challenges.
From time and temperature sensitivity to patient-facing services and integrated platforms, a seamless vein-to-vein supply chain is central in maintaining cell immunotherapy safety and efficacy at scale and maximizing the patient experience.
Industry experts from large pharma, biotech, standards agencies and supply chain and logistics service providers join this virtual event.
From the BINOCS team, Joachim Lasoen will be represented!
Looking forward to meeting you virtually!